were collected using a Kratos Axis Ultra DLD spectrometer (Kratos
Analytical, Manchester, U.K.) with a monochromatic Al Kα radiation
(1486.6 eV) at a pass energy of 20 and 160 eV for high resolution
and survey spectra, respectively. To achieve better resolution and
to avoid nonhomogeneous electric charge of nonconducting powders,
a commercial Kratos charge neutralizer was used. Binding energy (BE)
scale was calibrated using Au 4f7/2 at 84.0 eV and Cu 2p3/2 at 932.67 eV. A double-sided Cu tape was used to place
the powder samples on a stainless steel holder.
Data analysis
was conducted using CasaXPS (
component of the C 1s peak at a BE of 284.8 eV for each sample. The
atomic concentrations of each element were calculated after a Shirley
background subtraction considering the corresponding Scofield atomic
sensitivity factors and the contribution due to different inelastic
mean free paths of photoelectrons. The XPS data were averaged over
at least four spots spatially separated to avoid possible X-ray damage.
The atomic concentrations were then converted to drug concentrations
in mass percentage.